Stay updated on Glycine Supplement for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.

Latest updates to the Glycine Supplement for Severe COVID-19 Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows revision v3.5.4, replacing the previous v3.5.3. This reflects a minor update to the site's revision labeling in the page metadata.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s software/display revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated to v3.5.2, replacing v3.5.0.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check110 days agoChange DetectedThis release adds Revision: v3.4.2 and removes an earlier funding notice, which are site-wide updates and do not modify the study page content or its data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Glycine Supplement for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.